Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8)

FASEB Journal

Volumn 21, Issue 10, 2007, Pages 2580-2591

  Gutiérrez Fernández, Ana ^a   Inada, Masaki ^d   Balbín, Milagros ^c   Fueyo, Antonio ^b   Pitiot, Ana S ^c   Astudillo, Aurora ^c   Hirose, Kenji ^d   Hirata, Michiko ^d   Shapiro, Steven D ^d   Noël, Agnès ^e   Werb, Zena ^f   Krane, Stephen M ^b   López Otín, Carlos ^a   Puente, Xose S ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b UNIVERSIDAD DE OVIEDO   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF LIÈGE   (Belgium)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Degradome; MMP 9; Neutrophil; Protease

Indexed keywords

COLLAGENASE 3; GELATINASE B; NEUTROPHIL COLLAGENASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW TRANSPLANTATION; COMPLEX FORMATION; CONTROLLED STUDY; INFLAMMATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WOUND CLOSURE; WOUND HEALING;

MUS;

EID: 34547735561     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-7860com     Document Type: Article

References (50)

1. Puente, X. S., Sánchez, L. M., Overall, C. M., and López-Otín, C. (2003) Human and mouse proteases: a comparative genomic approach. Nat. Rev. Genet. 4, 544-558
2. Coussens, L. M., and Werb, Z. (2002) Inflammation and cancer. Nature 420, 860-867
3. Parks, W. C., Wilson, C. L., and Lopez-Boado, Y. S. (2004) Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4, 617-629
4. Overall, C. M., and López-Otín, C. (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat. Rev. Cancer. 2, 657-672
5. Folgueras, A. R., Pendás, A. M., Sánchez, L. M., and López-Otín, C. (2004) Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int. J. Dev. Biol. 48, 411-424
6. Lund, L. R., Green, K. A., Stoop, A. A., Ploug, M., Almholt, K., Lilla, J., Nielsen, B. S., Christensen, I. J., Craik, C. S., Werb, Z., Dano, K., and Romer, J. (2006) Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J. 25, 2686-2697
7. Lund, L. R., Romer, J., Bugge, T. H., Nielsen, B. S., Frandsen, T. L., Degen, J. L., Stephens, R. W., and Dano, K. (1999) Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J. 18, 4645-4656
8. Mirastschijski, U., Haaksma, C. J., Tomasek, J. J., and Agren, M. S. (2004) Matrix metalloproteinase inhibitor GM 6001 attenuates keratinocyte migration, contraction and myofibroblast formation in skin wounds. Exp. Cell Res. 299, 465-475
9. Salonurmi, T., Parikka, M., Kontusaari, S., Pirila, E., Munaut, C., Salo, T., and Tryggvason, K. (2004) Overexpression of TIMP-1 under the MMP-9 promoter interferes with wound healing in transgenic mice. Cell Tissue Res. 315, 27-37
10. Beare, A. H., O'Kane, S., Krane, S. M., and Ferguson, M. W. (2003) Severely impaired wound healing in the collagenase-resistant mouse. J. Invest. Dermatol. 120, 153-163
11. Mirastschijski, U., Zhou, Z., Rollman, O., Tryggvason, K., and Agren, M. S. (2004) Wound healing in membrane-type-1 matrix metalloproteinase-deficient mice. J. Invest. Dermatol. 123, 600-602
12. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 61-65
13. Sabeh, F., Ota, I., Holmbeck, K., Birkedal-Hansen, H., Soloway, P., Balbin, M., Lopez-Otin, C., Shapiro, S., Inada, M., Krane, S., Allen, E., Chung, D., and Weiss, S. J. (2004) Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J. Cell Biol. 167, 769-781
14. Hartenstein, B., Dittrich, B. T., Stickens, D., Heyer, B., Vu, T. H., Teurich, S., Schorpp-Kistner, M., Werb, Z., and Angel, P. (2006) Epidermal development and wound healing in matrix metalloproteinase 13-deficient mice. J. Invest. Dermatol. 126, 486-496
15. Balbín, M., Fueyo, A., Knäuper, V., Pendás, A. M., López, J. M., Jiménez, M. G., Murphy, G., and López- Otín, C. (1998) Collagenase 2 (MMP-8) expression in murine tissue-remodeling processes. Analysis of its potential role in postpartum involution of the uterus. J. Biol. Chem. 273, 23959-23968
16. Herman, M. P., Sukhova, G. K., Libby, P., Gerdes, N., Tang, N., Horton, D. B., Kilbride, M., Breitbart, R. E., Chun, M., and Schonbeck, U. (2001) Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation 104, 1899-1904
17. Kiili, M., Cox, S. W., Chen, H. Y., Wahlgren, J., Maisi, P., Eley, B. M., Salo, T., and Sorsa, T. (2002) Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J. Clin. Periodontol. 29, 224-232
18. Pirila, E., Ramamurthy, N. S., Sorsa, T., Salo, T., Hietanen, J., and Maisi, P. (2003) Gelatinase A (MMP-2), collagenase-2 (MMP-8), and laminin-5 gamma2-chain expression in murine inflammatory bowel disease (ulcerative colitis). Dig. Dis. Sci. 48, 93-98
19. Pirila, E., Ramamurthy, N., Maisi, P., McClain, S., Kucine, A., Wahlgren, J., Golub, L., Salo, T., and Sorsa, T. (2001) Wound healing in ovariectomized rats: effects of chemically modified tetracycline (CMT-8) and estrogen on matrix metalloproteinases -8, -13 and type I collagen expression. Curr. Med. Chem. 8, 281-294
20. Nwomeh, B. C., Liang, H. X., Cohen, I. K., and Yager, D. R. (1999) MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J. Surg. Res. 81, 189-195
21. Balbín, M., Fueyo, A., Tester, A. M., Pendás, A. M., Pitiot, A. S., Astudillo, A., Overall, C. M., Shapiro, S. D., and López-Otín, C. (2003) Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat. Genet. 35, 252-257
22. Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., and Werb, Z. (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422
23. Peters, T., Sindrilaru, A., Hinz, B., Hinrichs, R., Menke, A., Al-Azzeh, E. A., Holzwarth, K., Oreshkova, T., Wang, H., Kess, D., Walzog, B., Sulyok, S., Sunderkotter, C., Friedrich, W., Wlaschek, M., Krieg, T., and Scharffetter-Kochanek, K. (2005) Wound-healing defect of CD18(-/-) mice due to a decrease in TGF-beta1 and myofibroblast differentiation. EMBO J. 24, 3400-3410
24. Westerhof, G. R., Ploemacher, R. E., Boudewijn, A., Blokland, I., Dillingh, J. H., McGown, A. T., Hadfield, J. A., Dawson, M. J., and Down, J. D. (2000) Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients. Cancer Res. 60, 5470-5478
25. Inada, M., Wang, Y., Byrne, M. H., Rahman, M. U., Miyaura, C., Lopez-Otin, C., and Krane, S. M. (2004) Critical roles for collagenase-3 (MMP13) in development of growth plate cartilage and in endochondral ossification. Proc. Natl. Acad. Sci. U. S. A. 101, 17192-17197
26. Low, Q. E., Drugea, I. A., Duffner, L. A., Quinn, D. G., Cook, D. N., Rollins, B. J., Kovacs, E. J., and DiPietro, L. A. (2001) Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice. Am. J. Pathol. 159, 457-463
27. Beare, A. H., Krane, S. M., and Ferguson, M. W. (2005) Variable impairment of wound healing in the heterozygous collagenase-resistant mouse. Wound. Repair. Regen. 13, 27-40
28. Martin, P. (1997) Wound healing-aiming for perfect skin regeneration. Science 276, 75-81
29. Singer, A. J., and Clark, R. A. (1999) Cutaneous wound healing. N. Engl. J. Med. 341, 738-746
30. Werner, S., and Grose, R. (2003) Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83, 835-870
31. Savill, J., Dransfield, I., Gregory, C., and Haslett, C. (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2, 965-975
32. Gueders, M. M., Balbín, M., Rocks, N., Foidart, J. M., Gosset, P., Louis, R., Shapiro, S., López-Otín, C., Noël, A., and Cataldo, D. D. (2005) Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation. J. Immunol. 175, 2589-2597
33. Ashcroft, G. S., Yang, X., Glick, A. B., Weinstein, M., Letterio, J. L., Mizel, D. E., Anzano, M., Greenwell-Wild, T., Wahl, S. M., Deng, C., and Roberts, A. B. (1999) Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat. Cell Biol. 1, 260-266
34. Hosokawa, R., Urata, M. M., Ito, Y., Bringas, P., Jr., and Chai, Y. (2005) Functional significance of Smad2 in regulating basal keratinocyte migration during wound healing. J Invest Dermatol 125, 1302-1309
35. Kjeldsen, L., Johnsen, A. H., Sengelov, H., and Borregaard, N. (1993) Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 268, 10425-10432
36. Nwomeh, B. C., Liang, H. X., Diegelmann, R. F., Cohen, I. K., and Yager, D. R. (1998) Dynamics of the matrix metalloproteinases MMP-1 and MMP-8 in acute open human dermal wounds. Wound. Repair. Regen. 6, 127-134
37. Ahokas, K., Skoog, T., Suomela, S., Jeskanen, L., Impola, U., Isaka, K., and Saarialho-Kere, U. (2005) Matrilysin-2 (matrix metalloproteinase-26) is upregulated in keratinocytes during wound repair and early skin carcinogenesis. J. Invest. Dermatol. 124, 849-856
38. Okada, A., Tomasetto, C., Lutz, Y., Bellocq, J. P., Rio, M. C., and Basset, P. (1997) Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J. Cell Biol. 137, 67-77
39. Hieta, N., Impola, U., Lopez-Otin, C., Saarialho-Kere, U., and Kahari, V. M. (2003) Matrix metalloproteinase-19 expression in dermal wounds and by fibroblasts in culture. J. Invest. Dermatol. 121, 997-1004
40. Ravanti, L., Toriseva, M., Penttinen, R., Crombleholme, T., Foschi, M., Han, J., and Kahari, V. M. (2001) Expression of human collagenase-3 (MMP-13) by fetal skin fibroblasts is induced by transforming growth factor beta via p38 mitogen-activated protein kinase. FASEB J. 15, 1098-1100
41. Mohan, R., Chintala, S. K., Jung, J. C., Villar, W. V., McCabe, F., Russo, L. A., Lee, Y., McCarthy, B. E., Wollenberg, K. R., Jester, J. V., Wang, M., Welgus, H. G., Shipley, J. M., Senior, R. M., and Fini, M. E. (2002) Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J. Biol. Chem. 277, 2065-2072
42. Bullard, K. M., Lund, L., Mudgett, J. S., Mellin, T. N., Hunt, T. K., Murphy, B., Ronan, J., Werb, Z., and Banda, M. J. (1999) Impaired wound contraction in stromelysin-1-deficient mice. Ann. Surg. 230, 260-265
43. Van Lint, P., Wielockx, B., Puimege, L., Noël, A., López-Otín, C., and Libert, C. (2005) Resistance of collagenase-2 (matrix metalloproteinase-8)-deficient mice to TNF-induced lethal hepatitis. J. Immunol. 175, 7642-7649
44. Van Lint, P., and Libert, C. (2006) Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev. 17, 217-223
45. Lobmann, R., Ambrosch, A., Schultz, G., Waldmann, K., Schiweck, S., and Lehnert, H. (2002) Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45, 1011-1016
46. Marini, S., Fasciglione, G. F., de Sanctis, G., D'Alessio, S., Politi, V., and Coletta, M. (2000) Cleavage of bovine collagen I by neutrophil collagenase MMP-8. Effect of pH on the catalytic properties as compared to synthetic substrates. J. Biol. Chem. 275, 18657-18663
47. Balbín, M., Fueyo, A., Knäuper, V., López, J. M., Alvarez, J., Sánchez, L. M., Quesada, V., Bordallo, J., Murphy, G., and López-Otín, C. (2001) Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J. Biol. Chem. 276, 10253-10262
48. Freije, J. M., Díez-Itza, I., Balbín, M., Sánchez, L. M., Blasco, R., Tolivia, J., and López-Otín, C. (1994) Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem. 269, 16766-16773
49. Owen, C. A., Hu, Z., López-Otín, C., and Shapiro, S. D. (2004) Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase. J. Immunol. 172, 7791-7803
50. Yan, L., Borregaard, N., Kjeldsen, L., and Moses, M. A. (2001) The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J. Biol. Chem. 276, 37258-37265